Clinicopathological Prognostic Model for Survival in Adult Patients With Secondary Hemophagocytic Lymphohistiocytosis
This model stratified sHLH patients into three risk groups with distinct survival outcomes, potentially guiding future therapy.
Authors
- Elizabeth Brém (ORCID: https://orcid.org/0000-0002-3265-9841)
- Lisa X. Lee (ORCID: https://orcid.org/0000-0002-0664-2253)
- Ghayda’ E’leimat
- Ashley Gamayo
- Sherif Rezk (ORCID: https://orcid.org/0000-0003-4652-2130)
- Jack Reid (ORCID: https://orcid.org/0009-0003-8701-9504)
- Yen Cao
- Pongthep Vittayawacharin (ORCID: https://orcid.org/0000-0002-1131-5564)
- Piyanuch Kongtim (ORCID: https://orcid.org/0000-0003-2130-7645)
- Stefan O. Ciurea (ORCID: https://orcid.org/0000-0001-8597-3271)
- Benjamin J. Lee (ORCID: https://orcid.org/0000-0002-1678-1345)
Institutions
- Siriraj Hospital (TH)
- University of California, Irvine (US)
- Mahidol University (TH)
- UC Irvine Health (US)
Publication Details
- Journal
- European Journal Of Haematology
- Published
- 2025-03-15
- DOI
- https://doi.org/10.1111/ejh.14412
- Primary Topic
- Autoimmune and Inflammatory Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00